XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities:      
Net loss $ (15,343) $ (2,602) $ (11,799)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,381 1,904 2,931
Amortization of debt discounts and financing issuance costs 168    
Long-lived asset impairment 411    
Change in carrying value of contingent liability (668)    
Provision for adjustments to accounts receivable and doubtful accounts 70 31 347
Provision for excess and obsolete inventory 11 48 124
Loss on disposal of fixed assets 27 1  
Tax benefits from stock-based compensation   (5)  
Non-cash compensation related to stock options and restricted stock 1,528 2,158 3,652
Deferred income taxes (137)   (2)
Change in operating accounts:      
Accounts receivable 3,368 40 (1,000)
Income tax receivable 115 688 (7)
Inventories 16 10 (54)
Prepaid expenses and other assets 344 92 114
Accounts payable and accrued liabilities (1,966) (1,362) (2,189)
Deferred revenue (828) (1,058) 1,034
Net cash used in operating activities (11,503) (55) (6,849)
Investing activities:      
Acquisition of Birdstep Technology, net of cash received (1,927)    
Acquisition of iMobileMagic, net of cash received (558)    
Capital expenditures (500) (124) (216)
Proceeds from the sale of short-term investments 4,079   198
Purchases of short-term investments   (1,199)  
Net cash provided by (used in) investing activities 1,094 (1,323) (18)
Financing activities:      
Cash received from issuance of common stock, net of offering costs     5,242
Cash received from related-party notes payable, net of issuance costs ($97) 1,903    
Cash received from notes payable, net of issuance costs ($97) 1,903    
Cash received from stock sale for employee stock purchase plan 13 17 21
Cash received from exercise of stock options   10 6
Tax benefits received from stock-based compensation   5  
Net cash provided by financing activities 3,819 32 5,269
Net decrease in cash and cash equivalents (6,590) (1,346) (1,598)
Cash and cash equivalents, beginning of period 8,819 10,165 11,763
Cash and cash equivalents, end of period 2,229 8,819 10,165
Supplemental disclosures of cash flow information:      
Cash paid for income taxes 27 17 $ 75
Cash paid for interest expense 21    
Change in unrealized gain (loss) on short-term investments $ 2 $ (1)